Ensartinib (X-396), an Approved ALK Inhibitor, Falls Out as a Clinically Relevant ROS1 Inhibitor. Zhu VW, Ou SI. J Thorac Oncol 2021;16:1778-1781.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhu VW, Ou SI. Ensartinib (X-396), an Approved ALK Inhibitor, Falls Out as a Clinically Relevant ROS1 Inhibitor. J Thorac Oncol 2021;16:1778-1781.
PMID: 34715999